Cordis Opens Facility in Ireland

Dec. 3, 2008
Plant will make the company's newest stent technology.

Medical device manufacturer Cordis Corp. opened a high-tech 180,000-square-foot facility in Cashel, Ireland, where the Johnson & Johnson subsidiary will make next-generation drug-eluting stents, the company said Dec. 2.

In addition to production capabilities, the facility features a development laboratory and a finished-goods testing facility.

The plant currently employs 100 people during its first phase of development. When fully operational by late 2009 or early 2010, the facility will employ approximately 450 additional people, according to company spokesman Christopher Allman.

The new stent, known as the NEVO Sirolimus-eluting Coronary Stent, is currently being evaluated in two major clinical trials around the world, the company said. It's designed for treatment of patients suffering from coronary artery disease and utilizes a technology that incorporates hundreds of small reservoirs, each acting as a depot into which drug-polymer compositions are loaded. The design allows drug delivery from an implant, the surface of which is 75% polymer-free bare metal upon insertion and becomes fully bare metal following drug delivery and polymer bioresorption in approximately three months.

Johnson & Johnson has five facilities in Ireland and has been operating in the country for more than 50 years.

Popular Sponsored Recommendations

Empowering the Modern Workforce: The Power of Connected Worker Technologies

March 1, 2024
Explore real-world strategies to boost worker safety, collaboration, training, and productivity in manufacturing. Emphasizing Industry 4.0, we'll discuss digitalization and automation...

3 Best Practices to Create a Product-Centric Competitive Advantage with PRO.FILE PLM

Jan. 25, 2024
Gain insight on best practices and strategies you need to accelerate engineering change management and reduce time to market. Register now for your opportunity to accelerate your...

Transformative Capabilities for XaaS Models in Manufacturing

Feb. 14, 2024
The manufacturing sector is undergoing a pivotal shift toward "servitization," or enhancing product offerings with services and embracing a subscription model. This transition...

Shifting Your Business from Products to Service-Based Business Models: Generating Predictable Revenues

Oct. 27, 2023
Executive summary on a recent IndustryWeek-hosted webinar sponsored by SAP

Voice your opinion!

To join the conversation, and become an exclusive member of IndustryWeek, create an account today!